The prohibitin-binding compound fluorizoline induces apoptosis in chronic lymphocytic leukemia cells ex vivo but fails to prevent leukemia development in a murine model
Marina Wierz,
Sandrine Pierson,
Nora Chouha,
Laurent Désaubry,
Jean-Hugues François,
Guy Berchem,
Jerome Paggetti,
Etienne Moussay
Affiliations
Marina Wierz
Laboratory of Experimental Cancer Research, Department of Oncology, Luxembourg Institute of Health, Luxembourg
Sandrine Pierson
Laboratory of Experimental Cancer Research, Department of Oncology, Luxembourg Institute of Health, Luxembourg
Nora Chouha
Laboratory of Therapeutic Innovation (UMR 7200) CNRS/Université de Strasbourg, Faculté de Pharmacie, Illkirch, Luxembourg
Laurent Désaubry
Laboratory of Therapeutic Innovation (UMR 7200) CNRS/Université de Strasbourg, Faculté de Pharmacie, Illkirch, Luxembourg
Jean-Hugues François
Centre Hospitalier de Luxembourg, Luxembourg
Guy Berchem
Laboratory of Experimental Cancer Research, Department of Oncology, Luxembourg Institute of Health, Luxembourg;Centre Hospitalier de Luxembourg, Luxembourg
Jerome Paggetti
Laboratory of Experimental Cancer Research, Department of Oncology, Luxembourg Institute of Health, Luxembourg
Etienne Moussay
Laboratory of Experimental Cancer Research, Department of Oncology, Luxembourg Institute of Health, Luxembourg
